View Older Stories View More Recent Stories

Nov 5, 2025 08:16AM Raymond James on Biohaven Pharmaceutical Holding (BHVN): 'Meaningful Value Remains', 'Sticking with it'
Nov 5, 2025 06:10AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $42 at Baird
Nov 5, 2025 01:56AM FDA rejects Biohaven drug application for rare brain disorder
Nov 3, 2025 10:00AM Truist: 'QURE Update Minimal Read-Through To PTCT & WVE, In Our View'
Nov 3, 2025 09:24AM Raymond James on Biohaven (BHVN) Amid News Shock: 'QURE Sympathy Move Seems Misplaced'
Nov 3, 2025 07:38AM Biohaven Pharma (BHVN) Weakness May Be Tied to uniQure (QURE) Setback in Huntington's Disease
Sep 17, 2025 05:55AM Citi Starts Biohaven Pharmaceutical Holding (BHVN) at Buy
Sep 16, 2025 09:32AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $26 at UBS
Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'
Aug 30, 2025 04:00PM Why public perception matters so much for biotech valuations
Aug 25, 2025 05:05AM Increasing unusual put option volume: FIVN OPEN BHVN XLB XLI ONDS LQDA ROST
Aug 22, 2025 07:04AM Biohaven receives FDA update on troriluzole drug application
Aug 19, 2025 05:05AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at BTIG
Aug 12, 2025 06:41AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $30 at H.C. Wainwright
Aug 12, 2025 04:58AM Increasing unusual put option volume: OPEN BHVN ATYR TAP SBET XLP ACN LITE MSOS DOCN SHW
Aug 11, 2025 07:48AM Biohaven Pharma (BHVN) Tops Q2 EPS by 31c
Jul 22, 2025 05:52PM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven
Jul 22, 2025 04:00PM BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 22, 2025 01:31PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN
Jul 20, 2025 03:35PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN
Jul 20, 2025 10:50AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven
Jul 19, 2025 03:30PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN
Jul 18, 2025 06:00PM Kirby McInerney LLP Reminds Biohaven Ltd. (BHVN) Investors of Class Action Filing and Encourages Investors to Contact the Firm
Jul 18, 2025 03:17PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BHVN
Jul 16, 2025 04:00PM BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 30, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
May 29, 2025 10:59AM Morgan Stanley Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
May 29, 2025 07:29AM TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN'
May 28, 2025 03:00PM Biohaven Pharma (BHVN) Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day
May 28, 2025 07:32AM Biohaven Pharma (BHVN) Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates
May 13, 2025 09:43AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $54 at RBC Capital
May 12, 2025 04:57PM Biohaven Pharma (BHVN) Misses Q1 EPS by 47c
Apr 28, 2025 07:31AM Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital
Apr 28, 2025 05:47AM Biohaven Pharma (BHVN) call put ratio 2 call to 1 put with a focus on May calls
Apr 25, 2025 10:09AM Biohaven Pharma (BHVN) Halted on Volatility Down 18%
Apr 25, 2025 10:08AM Biohaven Pharma (BHVN) Withdraws Application For Troriluzole In EU
Apr 21, 2025 05:19AM Increasing unusual call option volume: XND HTZ UMC BHVN UMC AMCR HDB AEVA NICE FTI
Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'
Mar 26, 2025 07:02AM Avalo Therapuetics (AVTX) Appoints Michael Heffernan as Chairman of the Board
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 7, 2025 06:42AM Piper Sandler on Biohaven Pharmaceutical Holding (BHVN): 'Industry-Leading Pipeline Continues to Mature'
Mar 6, 2025 10:16AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $63 at Morgan Stanley
Mar 5, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Mar 5, 2025 05:21AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $63 at Jefferies
Mar 4, 2025 10:39AM TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'BHV-1300 Is Crushing Its Target'
Mar 4, 2025 10:26AM RBC on Biohaven Pharmaceutical Holding (BHVN): 'Stock Reaction Overdone On Bipolar Miss'
Mar 4, 2025 06:52AM Bernstein: 'Still like Biohaven Pharmaceutical Holding (BHVN) Stock but No Longer a Top Pick'; PT Lowered
Mar 3, 2025 04:25PM Biohaven Pharma (BHVN) Misses Q4 EPS by 11c
Mar 3, 2025 12:35PM Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
View More Recent Stories View Older Stories